News & Press Releases

BIOCENTURY – BC INNOVATIONS | EMERGING COMPANY PROFILE

CEO Doug Manion discusses how Kleo Pharmaceuticals Inc. is tapping small molecules’ advantages over biologics by synthesizing compounds that mimic or modify the functions of antibodies as cancer immunotherapies. BioCentury.com (Subscription required)

Print Friendly, PDF & Email

Upcoming Events:

October 2020
No event found!